Canagliflozin in Advanced Renal Disease With MRI Endpoints

Clinical trial NCT06182839 · RECRUITING

Trial details

NCT number: NCT06182839
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ESRD, CKD Stage 4, CKD Stage 5

Start date: 2024-05-01
Primary completion: 2028-03-30
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.